Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Plastic Surgery

Edition

30-Second Takeaway

  • Pre-pectoral implants show comparable complications and no delay to adjuvant therapy versus sub-pectoral placement.
  • Next-generation craniofacial implants are moving toward patient-specific, bioactive, additively manufactured constructs.
  • Bioactive scaffolds on 3D-printed titanium markedly enhance bone ingrowth in critical craniofacial defects.
  • Engineered decellularized human cartilage achieves full skeletal repair in animals with intrinsic immunosuppression.
  • Emerging bioresorbable neural and electroceutical devices may transform pain control, nerve repair, and chronic wound care.

Week ending January 10, 2026

Highlights in Breast, Craniofacial, Nerve, and Regenerative Reconstruction

Pre-pectoral vs sub-pectoral implants: similar complications and no delay in adjuvant therapy

CANCERSJan 10, 2026

In this 10-year single-center series of 622 immediate implant reconstructions, overall complication rates were similar for sub-pectoral and pre-pectoral placement. Pre-pectoral reconstruction had more delayed wound healing, whereas sub-pectoral placement showed more postoperative bleeding. Despite differing complication profiles, the reconstruction plane did not independently delay initiation of adjuvant therapy on multivariate analysis. Smoking, diabetes, and skin-reducing mastectomy predicted delayed adjuvant treatment, not implant position. Pre-pectoral reconstruction also reduced operative time compared with sub-pectoral techniques.

Next-generation craniomaxillofacial implants emphasize the “3Bs” and patient-specific design

INTERNATIONAL JOURNAL OF ORAL SCIENCEJan 4, 2026

This narrative review synthesizes advances in craniomaxillofacial implants focusing on biomechanics, biocompatibility, and bioactivity. Emerging materials such as bioresorbable polymers, magnesium alloys, and ceramic composites enable safer, more functional, patient-specific devices. Triply periodic minimal surface architectures and additive manufacturing allow tailored mechanical performance and enhanced tissue integration. The authors highlight AI-driven design, real-time monitored 3D printing, and advanced biological testing as key future directions. Clinical translation will depend on tight collaboration between surgeons, materials scientists, and computational engineers.

Bioactive peptide–hyaluronic acid scaffolds enhance bone ingrowth into 3D-printed titanium

ADVANCED HEALTHCARE MATERIALSJan 5, 2026

This preclinical study couples porous 3D-printed titanium with a nanofibrillar peptide–hyaluronic acid scaffold for critical-size calvarial defects in rabbits. The scaffold improved in vitro osteoblast-like cell adhesion and enzymatic stability compared with unmodified titanium surfaces. In vivo, scaffold-integrated implants significantly increased inner bone volume and improved trabecular architecture versus inert titanium controls. Hydrogel-delivered scaffold nearly doubled inner bone volume, with histology showing better bone–implant integration and active periosteum. The acellular, growth factor–free design offers a potentially translatable strategy for personalized craniofacial bone reconstruction.

Decellularized engineered human cartilage graft fully repairs rat femoral defects

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAJan 9, 2026

This study presents engineered human cartilage that is subsequently decellularized to create an extracellular matrix–only graft. In immunocompetent and immunocompromised animals, ectopic implantation preserved the graft’s osteoinductive properties, guided by macrophage polarization kinetics. In vitro allogeneic coculture assays showed the decellularized cartilage suppressed macrophage and dendritic cell maturation and reduced T cell activation. In a rat orthotopic critical-sized femoral defect model, the graft achieved full morphological and mechanical restoration. These data suggest an off-the-shelf, immunosuppressive cartilage-derived graft platform ready for first-in-human skeletal repair trials.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Pre-pectoral breast reconstruction appears oncologically safe regarding time to adjuvant therapy, with a distinct complication profile versus sub-pectoral.
  • Advanced materials, architectures, and manufacturing are converging to deliver personalized, bioactive skeletal and soft-tissue implants.
  • Cartilage and skin tissue engineering platforms are maturing toward off-the-shelf grafts with controlled mechanical conditioning and immune interactions.